In a 24-week randomized placebo-controlled trial, volunteers with elevated uric acid levels who received twice-daily capsules of 500 mg T. bellerica extract demonstrated a notable 9.8% average decrease in uric acid levels after only 4 weeks. At the end of the study, uric acid levels were reduced by a remarkable 28.4%, with no reported adverse side effects.1
This decrease in uric acid levels enabled 89% of the participants who were taking the extract to achieve targeted uric acid serum levels.
Further, evidence from pre-clinical studies suggest that the bioactive compounds in T. bellerica may also help support a healthy response to inflammatory factors and has antioxidant properties.2,3
Ayuric® is a registered trademark of Natreon, Inc. with patents pending.
|Dosage and Use
|These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.